
Japanese biomedical scientists have achieved a breakthrough that could mark a major turning point in modern medicine — they have successfully created a type of artificial blood that is compatible with all blood groups. This innovative product is not recognized as foreign by the human body and can be used for almost all patients.
Hemoglobin-based, virus-free
According to the scientists, the artificial blood is produced from hemoglobin extracted from expired donor blood. This hemoglobin is encapsulated in a protective shell and purified to be free from any viruses or infections. Due to the absence of antigens, it is completely compatible with all blood types.
Clinical trials were successful
Scientific research on artificial blood began in 2022. Since then, clinical trials have shown no side effects or complications. This allows the product to be considered safe and effective. The researchers stated that mass production and hospital distribution are expected by 2030.
Another advantage — long-term storage
Another significant feature of the new artificial blood is its ability to be stored at room temperature for up to two years. This makes it easy to transport and store without special refrigeration — particularly useful during emergencies or for sending humanitarian aid abroad.
Conclusion: A new era begins in medicine
The universal artificial blood created by Japanese scientists could be a major solution to the global blood shortage problem. It is compatible with all blood groups, safe, and can be stored for long periods — making it a revolutionary development in healthcare. A new chapter in medical history may be starting. Read 'Zamin' on Telegram!
Ctrl
Enter
Did you find a Mistake?
Highlight the phrase and press Ctrl+Enter Related News